Initially, it seemed that cDC1 was the only DC subset involved in tumor immunity, however a more extensive analysis revealed the presence of other DC subsets [98] and the limited prevalence of cDC1 in human tumors [99]. This evidence concerns the gene MPPE1 and neoplasm.